Stay updated on Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.

Latest updates to the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5 in the release notes metadata.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, reflecting a new version of the page's metadata. The change does not affect the study information presented.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing v3.6.3, indicating a site version update.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision label was updated to v3.6.3, indicating a minor backend or documentation update; no user-facing content appears to be affected.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision tag was updated to v3.6.2, reflecting a minor update to the page's revision history rather than substantive changes to study details.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page now includes a 'No longer looking for participants' notice and new help sections, including 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and the 'Intervention/Treatment' topic. The revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.